Lower Risk of Self-Harm During Pregnancy, Except in Younger Women
Lower risk for self-harm was observed during pregnancy, except in women aged 15 to 19 years.
Lower risk for self-harm was observed during pregnancy, except in women aged 15 to 19 years.
Intranasal oxytocin improves mood in postpartum women but has no impact on mood in women with more severe depressive symptoms.
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
The Women's Mental Health Program at the University of Arkansas for Medical Sciences has observed a fourfold increase in postpartum psychosis in the pandemic.
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
While the role that COVID-19 plays in the pathophysiology of PP is not established, this study offers preliminary evidence that provides us a stronger grasp of how certain viral infections, like coronavirus, can predispose to postpartum psychiatric illnesses.
Because pregnant and postpartum women face unique challenges in the context of the COVID-19 pandemic, they may be at increased risk for mental health problems in this setting. In a recent study, researchers from the University College of London surveyed 162 new mothers in London between May and June 2020 using a social network survey designed to assess the impact of the COVID-19 lockdown.
While the risk of severe COVID in pregnant women is relatively low, pregnant women with severe COVID experience worse outcomes. Some of our perinatal patients can’t wait to get a COVID-19 vaccine, some of our [...]